Roberto Collado-Borrell

14PUBLICATIONS
30CO-AUTHORS
Inter-organisational, extra-organisational and global information systemsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematologyReproductive medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 06, 2026
Use of Information and Communication Technologies in Patients With Cancer Receiving Antineoplastic or Supportive Therapy: Comparative Cross-Sectional Survey.

|Jan 19, 2026
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing.

Carolina Pizarro-Gómez, Roberto Collado-Borrell, Vicente Escudero-Vilaplana

|Jul 23, 2024
Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.

Beatriz Somoza-Fernández, Vicente Escudero-Vilaplana, Roberto Collado-Borrell

|Mar 08, 2023
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.

Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro

|Feb 22, 2023
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.

Javier De Castro, Amelia Insa, Roberto Collado-Borrell

|Dec 08, 2022
Possible heart failure caused by osimertinib in a lung cancer patient.

Paula Ruiz-Briones, Vicente Escudero-Vilaplana, Roberto Collado-Borrell

Pageof 3

Frequent Collaborators

14 joint publications

Vicente Escudero-Vilaplana

6 joint publications

Ana Herranz-Alonso

6 joint publications

Maria Sanjurjo-Saez

3 joint publications

Cristina Villanueva-Bueno